Ganoderenic acid ACAS# 100665-40-5 |
2D Structure
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 100665-40-5 | SDF | Download SDF |
PubChem ID | 6442088 | Appearance | Powder |
Formula | C30H42O7 | M.Wt | 514.7 |
Type of Compound | Triterpenoids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | (E)-6-[(7S,10S,13R,14R,15S,17R)-7,15-dihydroxy-4,4,10,13,14-pentamethyl-3,11-dioxo-2,5,6,7,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxohept-5-enoic acid | ||
SMILES | CC(CC(=O)C=C(C)C1CC(C2(C1(CC(=O)C3=C2C(CC4C3(CCC(=O)C4(C)C)C)O)C)C)O)C(=O)O | ||
Standard InChIKey | OVUOUFPIPZJGME-HRKVNZLKSA-N | ||
Standard InChI | InChI=1S/C30H42O7/c1-15(10-17(31)11-16(2)26(36)37)18-12-23(35)30(7)25-19(32)13-21-27(3,4)22(34)8-9-28(21,5)24(25)20(33)14-29(18,30)6/h10,16,18-19,21,23,32,35H,8-9,11-14H2,1-7H3,(H,36,37)/b15-10+/t16?,18-,19+,21?,23+,28+,29-,30+/m1/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1. Ganoderenic acid A show inhibitory activity on human aldose reductase in vitro. 2. Ganoderenic acid A has a potent hepatoprotective effect against CCl4-induced liver injury. 3. Ganoderenic acid A has cytotoxic activity, their inhibitory activities against human HeLa cervical cancer cell lines. |
Ganoderenic acid A Dilution Calculator
Ganoderenic acid A Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 1.9429 mL | 9.7144 mL | 19.4288 mL | 38.8576 mL | 48.572 mL |
5 mM | 0.3886 mL | 1.9429 mL | 3.8858 mL | 7.7715 mL | 9.7144 mL |
10 mM | 0.1943 mL | 0.9714 mL | 1.9429 mL | 3.8858 mL | 4.8572 mL |
50 mM | 0.0389 mL | 0.1943 mL | 0.3886 mL | 0.7772 mL | 0.9714 mL |
100 mM | 0.0194 mL | 0.0971 mL | 0.1943 mL | 0.3886 mL | 0.4857 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Desloratadine
Catalog No.:BCC4540
CAS No.:100643-71-8
- (-)-Epipinoresinol
Catalog No.:BCN3377
CAS No.:10061-38-8
- MK-2894 sodium salt
Catalog No.:BCC1758
CAS No.:1006036-88-9
- MK-2894
Catalog No.:BCC1757
CAS No.:1006036-87-8
- NF 546
Catalog No.:BCC7804
CAS No.:1006028-37-0
- TAK-593
Catalog No.:BCC5142
CAS No.:1005780-62-0
- TC ASK 10
Catalog No.:BCC6301
CAS No.:1005775-56-3
- Monomethylsulochrin
Catalog No.:BCN7255
CAS No.:10056-14-1
- Tirasemtiv
Catalog No.:BCC5183
CAS No.:1005491-05-3
- LCL161
Catalog No.:BCC1691
CAS No.:1005342-46-0
- CVT 10216
Catalog No.:BCC5606
CAS No.:1005334-57-5
- Gelomulide N
Catalog No.:BCN6641
CAS No.:1005212-02-1
- Ganoderenic acid B
Catalog No.:BCN7966
CAS No.:100665-41-6
- Ganoderenic acid C
Catalog No.:BCN3210
CAS No.:100665-42-7
- Ganoderenic acid D
Catalog No.:BCN2445
CAS No.:100665-43-8
- Deacetyl ganoderic acid F
Catalog No.:BCN2870
CAS No.:100665-44-9
- 3-(Hydroxymethyl)cyclopentanol
Catalog No.:BCN5822
CAS No.:1007125-14-5
- CH5132799
Catalog No.:BCC4991
CAS No.:1007207-67-1
- 1-O-Deacetylkhayanolide E
Catalog No.:BCN5823
CAS No.:1007387-95-2
- Ganoderic acid M
Catalog No.:BCN2871
CAS No.:100761-17-9
- (R)-5-Hydroxy-1,7-diphenyl-3-heptanone
Catalog No.:BCN3591
CAS No.:100761-20-4
- Chlorahololide C
Catalog No.:BCN7256
CAS No.:1007859-25-7
- 4,4'-Bis(α,α-dimethylbenzyl)diphenylamine
Catalog No.:BCC8661
CAS No.:10081-67-1
- (RS)-CPP
Catalog No.:BCC6561
CAS No.:100828-16-8
Beta-glucuronidase-inhibitory activity and hepatoprotective effect of Ganoderma lucidum.[Pubmed:10077435]
Biol Pharm Bull. 1999 Feb;22(2):162-4.
To prove the relationship between the fluctuation in serum beta-glucuronidase level and hepatotoxicity, an inhibitor of beta-glucuronidase from G. lucidum was isolated and its hepatoprotective activity was investigated. The ether fraction of G. lucidum, which had potent beta-glucuronidase-inhibitory activity, protected against CCl4-induced liver injury. From this ether fraction, Ganoderenic acid A, was isolated as the potent inhibitor of beta-glucuronidase. It had a potent hepatoprotective effect against CCl4-induced liver injury. These results suggest that the beta-glucuronidase seems to be closely related to liver injury, which could be prevented by beta-glucuronidase inhibitors.
Inhibition of aldose reductase in vitro by constituents of Ganoderma lucidum.[Pubmed:20379959]
Planta Med. 2010 Oct;76(15):1691-3.
CHCl(3) extract of the fruiting body of Ganoderma lucidum was found to show inhibitory activity on human aldose reductase in vitro. From the acidic fraction, potent human aldose reductase inhibitors, ganoderic acid C2 (1) and Ganoderenic acid A (2), were isolated together with three related compounds. It was found that the free carboxyl group of ganoderic acid C2 and Ganoderenic acid A is essential in eliciting the inhibitory activity considering the much lower activity of their methyl esters.